Brain metastases in patients with ovarian carcinoma: Prognostic factors and outcome

Journal of Neuro-Oncology

Volumn 66, Issue 3, 2004, Pages 313-325

  Cohen, Zvi R ^a,e   Suki, Dima ^b   Weinberg, Jeffrey S ^b   Marmor, Eric ^d   Lang, Frederick F ^b   Gershenson, David M ^c   Sawaya, Raymond ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b Box 316   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Brain; Metastasis; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MELPHALAN; PACLITAXEL; STEROID;

ABDOMINAL HYSTERECTOMY; ADRENAL METASTASIS; ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BRAIN RADIATION; CANCER CENTER; CANCER GRADING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIZZINESS; EXCISION; FEMALE; HEADACHE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; OVARY CARCINOMA; PANCREAS DISEASE; PROGNOSIS; RADIOSURGERY; SALPINGOOOPHORECTOMY; SEIZURE; SKIN METASTASIS; SPLEEN DISEASE; STATISTICAL ANALYSIS; STEREOTAXIC SURGERY; SURVIVAL TIME; SYMPTOMATOLOGY; THYROID DISEASE; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA, MUCINOUS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARCINOMA, ENDOMETRIOID; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; STEREOTAXIC TECHNIQUES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 1342291008     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000014516.04943.38     Document Type: Article

References (25)

1. Cancer facts and figures. American Cancer Society, Atlanta, GA. http://www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pdf, 2002
2. LeRoux PD, Berger MS, Elliott JP, Tamimi HK: Cerebral metastases from ovarian carcinoma. Cancer 67: 2194-2199, 1991
3. Rodriguez GC, Soper JT, Berchuck A, Oleson J, Dodge R, Montana G, Clarke-Pearson DL: Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery. J Clin Oncol 10: 1553-1560, 1992
4. Bruzzone M, Campora E, Chiara S, Giudici S, Merlini L, Simoni C, Mammoliti S, Rubagotti A, Rosso R: Cerebral metastases secondary to ovarian cancer: Still an unusual event. Gynecol Oncol 49: 37-40, 1993
5. Hardy JR, Harvey VJ: Cerebral metastases in patients with ovarian cancer treated with chemotherapy. Gynecol Oncol 33: 296-300, 1989
6. Cormio G, Maneo A, Parma G, Pittelli MR, Miceli MD, Bonazzi C: Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review. Ann Oncol 6: 571-574, 1995
7. Geisler JP, Geisler HE: Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol 57: 246-249, 1995
8. Kaminsky-Forrett MC, Weber B, Conroy T, Spaeth D: Brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer 10: 366-371, 2000
9. Sood A, Kumar L, Sood R, Sandhu MS: Epithelial ovarian carcinoma metastatic to the central nervous system: A report on two cases with review of literature. Gynecol Oncol 62: 113-118, 1996
10. Mayer RJ, Berkowitz RS, Griffiths CT: Central nervous system involvement by ovarian carcinoma: A complication of prolonged survival with metastatic disease. Cancer 41: 776-783, 1978
11. Dauplat J, Nieberg RK, Hacker NF: Central nervous system metastases in epithelial ovarian carcinoma. Cancer 60: 2559-2562, 1987
12. Larson DM, Copeland LJ, Moser RP, Malone Jr., JM, Gershenson DM, Wharton JT: Central nervous system metastases in epithelial ovarian carcinoma. Obstet Gynecol 68: 746-750, 1986
13. Henriquez I, Castro C, Berenguer J, Biete A: Calcification of presumed ovarian carcinoma brain metastases following radiotherapy. Br J Radiol 72: 85-88, 1999
14. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494-500, 1990
15. Cormio G, Gabriele A, Maneo A, Zanetta G, Bonazzi C, Landoni F: Complete remission of brain metastases from ovarian carcinoma with carboplatin. Eur J Obstet Gynecol Reprod Biol 8: 91-93, 1998
16. Bindal RK, Sawaya R, Leavens ME, Lee JJ: Surgical treatment of multiple brain metastases. J Neurosurg 79: 210-216, 1993
17. Bindal AK, Bindal RK, Hess KR, Shiu A, Hassenbusch SJ, Shi WM, Sawaya R: Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 84: 748-754, 1996
18. Schoggl A, Kitz K, Reddy M, Wolfsberger S, Schneider B, Dieckmann K, Ungersbock K: Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 142: 621-626, 2000
19. Kawana K, Yoshikawa H, Yokota H, Onda T, Nakagawa K, Tsutsumi O, Taketani Y: Successful treatment of brain metastases from ovarian cancer using gamma-knife radiosurgery. Gynecol Oncol 65: 357-359, 1997
20. Barker GH, Orledge J, Wiltshaw E: Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynaecol 88: 690-694, 1981
21. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR: The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6: 1-9, 1980
22. Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 19: 579-592, 1978
23. Jekunen AP, Christen RD, Shalinsky DR, Howell SB: Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. Br J Cancer 69: 299-306, 1994
24. Ozols RF: Carboplatin and taxol (paclitaxel) in advanced ovarian carcinoma. Ann Oncol 5 (suppl 6): S39-S43, 1994
25. Yamamoto K, Kikuchi Y, Kudoh K, Nagata I: Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. J Cancer Res Clin Oncol 126: 168-172, 2000